Shenzhen Neptunus Interlong Bio-technique Company Limited (NEP Interlong) has tabled a comprehensive governance revamp that will:
1. Amend its Articles of Association to align with China Securities Regulatory Commission (CSRC) rules, the 2025 Company Law revisions and Hong Kong’s updated GEM Listing Rules, while also embracing paper-less disclosure requirements. 2. Abolish the existing supervisory committee, transferring its oversight functions to the board and specialised committees once shareholders give approval.
The proposals were approved at a 29 May 2026 board meeting and will be put to shareholders via special resolution at the 25 June 2026 AGM, pending clearance from relevant PRC authorities. An AGM circular with full amendment text will be distributed in due course.
Board composition will also change:
• Non-executive Director Ms Yu Lin and Independent Non-executive Director Mr Zhang Jian Zhou will retire and not seek re-election. Both confirm no disagreements with the board.
• Nine nominees are slated for the new three-year board term (25 Jun 2026-24 Jun 2029): – Re-election: Mr Zhang Feng (Chairman & Executive Director), Mr Huang Jian Bo (Executive), Mr Zhang Xiao Guang (Executive), Mr Zhang Yi Fei (Non-executive), Mr Jin Rui (Non-executive & Audit Committee member), Mr Yick Wing Fat, Simon (INED & Audit Committee Chair), and Mr Poon Ka Yeung (INED & Remuneration Committee Chair). – New appointments: Mr Zhang Xiao Peng as Non-executive Director and Ms Zhu Jia Min as Independent Non-executive Director.
Remuneration for the two new appointees is set at RMB0.10 million per annum each, inclusive of tax, with either party able to terminate the service agreement on three months’ written notice. Both will serve on board committees as designated.
Following Ms Zhu’s appointment, the board will continue to meet GEM Listing Rule 5.05 requirements regarding independent representation.
Shareholders will vote on these governance changes and director nominations at the forthcoming AGM.
Comments